{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:22:06Z","timestamp":1767774126127,"version":"build-2238731810"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alma Mater Studiorum - Universit\u00e0 di Bologna"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Complete cytoreductive surgery is crucial in advanced ovarian cancer (OC) treatment. Diaphragmatic surgery, including stripping (DS) and resection (DR), is often necessary for optimal cytoreduction. However, postoperative complications and the timing of adjuvant chemotherapy initiation remain critical concerns. This study evaluates the impact of DR and DS on surgical outcomes, chemotherapy timing, and survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>This retrospective, monocentric study analyzed 215 patients with International Federation of Gynecology and Obstetrics (FIGO) stage III\u2013IV OC undergoing DS or DR between 2011 and 2023. Clinical, surgical, and survival data were collected; complications were graded using the Clavien\u2013Dindo system. Statistical analysis included contingency and survival tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 215 patients underwent diaphragmatic surgery: 122 patients (56.7%) underwent DR and 93 (43.3%) DS. No significant differences existed between groups regarding age, body mass index (BMI), histological subtype, American Society of Anesthesiologists (ASA) score, or primary\/interval debulking surgery distribution (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.122). DR was more common in patients with greater peritoneal disease (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.003), higher pleural involvement (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.002), and longer operative times (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.018). Postoperatively, DR was associated with increased thoracic complications (87.7% versus 52.7%,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001), greater oxygen supplementation needs (55.7% versus 35.5%,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.003), and elevated liver enzymes. However, no significant differences emerged in severe complications (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.077), reoperation rates (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.227), or time to chemotherapy initiation (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.742). A decreasing trend in thoracostomy tube placement was observed since 2018. Progression-free and overall survival were similar between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite requiring greater intraoperative effort and resulting in higher postoperative morbidity, DR is not associated with an increased incidence of severe complications (grade 3+) or delayed chemotherapy initiation compared with DS. These findings support the feasibility of DR for achieving complete cytoreduction in advanced OC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-18423-1","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T19:41:22Z","timestamp":1759606882000},"page":"1099-1108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Diaphragmatic Resection Versus Stripping in Advanced Ovarian Cancer: Impact on Patient Complications in a Large Retrospective Cohort Study at a Tertiary Referral Center"],"prefix":"10.1245","volume":"33","author":[{"given":"Pietro","family":"Pasquini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Genovesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia Alexandra","family":"Coad\u0103","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andi","family":"Stermasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Mezzapesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Di Costanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Bovicelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta Pia","family":"Bilancia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Fiuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierandrea","family":"De Iaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Myriam","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"key":"18423_CR1","unstructured":"Arora T, Mullangi S, Vadakekut ES, Lekkala MR. Epithelial ovarian cancer. In: StatPearls. StatPearls Publishing; 2025. Accessed February 1, 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567760\/"},{"issue":"10","key":"18423_CR2","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3390\/biomedicines9101316","volume":"9","author":"G Ravegnini","year":"2021","unstructured":"Ravegnini G, De Iaco P, Gorini F, et al. Role of circulating miRNAs in therapeutic response in epithelial ovarian cancer: a systematic revision. Biomedicines. 2021;9(10):1316. https:\/\/doi.org\/10.3390\/biomedicines9101316.","journal-title":"Biomedicines"},{"issue":"11","key":"18423_CR3","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1136\/ijgc-2020-001640","volume":"30","author":"A Fagotti","year":"2020","unstructured":"Fagotti A, Ferrandina MG, Vizzielli G, et al. Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850). Int J Gynecol Cancer. 2020;30(11):1657\u201364. https:\/\/doi.org\/10.1136\/ijgc-2020-001640.","journal-title":"Int J Gynecol Cancer."},{"issue":"12","key":"18423_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.107250","volume":"49","author":"C Taliento","year":"2023","unstructured":"Taliento C, Restaino S, Scutiero G, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in patients with ovarian cancer: A systematic review. Eur J Surg Oncol. 2023;49(12):107250. https:\/\/doi.org\/10.1016\/j.ejso.2023.107250.","journal-title":"Eur J Surg Oncol."},{"issue":"8","key":"18423_CR5","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1136\/ijgc-2022-004249","volume":"33","author":"AM Perrone","year":"2023","unstructured":"Perrone AM, Coada CA, Ravegnini G, et al. Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma. Int J Gynecol Cancer. 2023;33(8):1270\u20138. https:\/\/doi.org\/10.1136\/ijgc-2022-004249.","journal-title":"Int J Gynecol Cancer."},{"key":"18423_CR6","doi-asserted-by":"publisher","unstructured":"Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R. Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst Rev. 2011;2011(8):CD007565. https:\/\/doi.org\/10.1002\/14651858.CD007565.pub2","DOI":"10.1002\/14651858.CD007565.pub2"},{"key":"18423_CR7","doi-asserted-by":"publisher","unstructured":"Coada CA, Dondi G, Ravegnini G, et al. Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival. J Gynecol Oncol. 2023;34(6). https:\/\/doi.org\/10.3802\/jgo.2023.34.e82","DOI":"10.3802\/jgo.2023.34.e82"},{"issue":"8","key":"18423_CR8","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1136\/ijgc-2020-001243","volume":"30","author":"JA Dottino","year":"2020","unstructured":"Dottino JA, He W, Sun CC, et al. National trends in bowel and upper abdominal procedures in ovarian cancer surgery. Int J Gynecol Cancer. 2020;30(8):1195\u2013202. https:\/\/doi.org\/10.1136\/ijgc-2020-001243.","journal-title":"Int J Gynecol Cancer."},{"issue":"11","key":"18423_CR9","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1245\/s10434-017-6005-1","volume":"24","author":"V Gallotta","year":"2017","unstructured":"Gallotta V, Ferrandina G, Vizzielli G, et al. Hepatoceliac lymph node involvement in advanced ovarian cancer patients: prognostic role and clinical considerations. Ann Surg Oncol. 2017;24(11):3413\u201321. https:\/\/doi.org\/10.1245\/s10434-017-6005-1.","journal-title":"Ann Surg Oncol."},{"key":"18423_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ygyno.2024.04.019","volume":"187","author":"A Rosati","year":"2024","unstructured":"Rosati A, De Rose AM, Gallotta V, et al. Feasibility and operative outcomes of surgery in the liver area in advanced ovarian cancer. Gynecol Oncol. 2024;187:98\u2013104. https:\/\/doi.org\/10.1016\/j.ygyno.2024.04.019.","journal-title":"Gynecol Oncol."},{"issue":"1","key":"18423_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ygyno.2017.02.023","volume":"145","author":"VD Sioulas","year":"2017","unstructured":"Sioulas VD, Schiavone MB, Kadouri D, et al. Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy? Gynecol Oncol. 2017;145(1):15\u201320. https:\/\/doi.org\/10.1016\/j.ygyno.2017.02.023.","journal-title":"Gynecol Oncol."},{"issue":"2","key":"18423_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/IGC.0000000000000597","volume":"26","author":"G Bogani","year":"2016","unstructured":"Bogani G, Ditto A, Martinelli F, et al. Surgical techniques for diaphragmatic resection during cytoreduction in advanced or recurrent ovarian carcinoma: a systematic review and meta-analysis. Int J Gynecol Cancer. 2016;26(2):371\u201380. https:\/\/doi.org\/10.1097\/IGC.0000000000000597.","journal-title":"Int J Gynecol Cancer."},{"issue":"2","key":"18423_CR13","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e14","volume":"31","author":"R Tozzi","year":"2020","unstructured":"Tozzi R, Ferrari F, Nieuwstad J, Campanile RG, Soleymani Majd H. Tozzi classification of diaphragmatic surgery in patients with stage IIIC-IV ovarian cancer based on surgical findings and complexity. J Gynecol Oncol. 2020;31(2):e14. https:\/\/doi.org\/10.3802\/jgo.2020.31.e14.","journal-title":"J Gynecol Oncol."},{"issue":"2","key":"18423_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0090-8258(90)90415-h","volume":"39","author":"E Brand","year":"1990","unstructured":"Brand E, Pearlman N. Electrosurgical debulking of ovarian cancer: a new technique using the argon beam coagulator. Gynecol Oncol. 1990;39(2):115\u20138. https:\/\/doi.org\/10.1016\/0090-8258(90)90415-h.","journal-title":"Gynecol Oncol."},{"key":"18423_CR15","unstructured":"Nieuwenhuyzen-de Boer. Cytoreductive surgery with the PlasmaJet improved quality-of-life for advanced stage ovarian cancer patients - PMC. Accessed May 7, 2025. https:\/\/pmc-ncbi-nlm-nih-gov.ezproxy.unibo.it\/articles\/PMC10416900\/"},{"issue":"8","key":"18423_CR16","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1471-0528.2009.02214.x","volume":"116","author":"E Ch\u00e9reau","year":"2009","unstructured":"Ch\u00e9reau E, Ballester M, Selle F, et al. Pulmonary morbidity of diaphragmatic surgery for stage III\/IV ovarian cancer. BJOG. 2009;116(8):1062\u20138. https:\/\/doi.org\/10.1111\/j.1471-0528.2009.02214.x.","journal-title":"BJOG."},{"issue":"2","key":"18423_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ygyno.2021.11.012","volume":"164","author":"S Cianci","year":"2022","unstructured":"Cianci S, Fedele C, Vizzielli G, et al. Surgical outcomes of diaphragmatic resection during cytoreductive surgery for advanced gynecological ovarian neoplasia: a randomized single center clinical trial - DRAGON. Gynecol Oncol. 2022;164(2):271\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2021.11.012.","journal-title":"Gynecol Oncol."},{"issue":"1","key":"18423_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ygyno.2022.05.002","volume":"166","author":"MA Angeles","year":"2022","unstructured":"Angeles MA, Hern\u00e1ndez A, P\u00e9rez-Benavente A, et al. The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer. Gynecol Oncol. 2022;166(1):8\u201317. https:\/\/doi.org\/10.1016\/j.ygyno.2022.05.002.","journal-title":"Gynecol Oncol."},{"issue":"2","key":"18423_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ygyno.2016.11.022","volume":"144","author":"BLL Seagle","year":"2017","unstructured":"Seagle BLL, Butler SK, Strohl AE, Nieves-Neira W, Shahabi S. Chemotherapy delay after primary debulking surgery for ovarian cancer. Gynecol Oncol. 2017;144(2):260\u20135. https:\/\/doi.org\/10.1016\/j.ygyno.2016.11.022.","journal-title":"Gynecol Oncol."},{"key":"18423_CR20","doi-asserted-by":"publisher","unstructured":"Chiva L, Ordas P, Mishra J, et al. SUROVA Study: Global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer. Int J Gynecol Cancer. 2025;35(2). https:\/\/doi.org\/10.1016\/j.ijgc.2025.101707","DOI":"10.1016\/j.ijgc.2025.101707"},{"issue":"3","key":"18423_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ygyno.2004.04.032","volume":"94","author":"W Cliby","year":"2004","unstructured":"Cliby W, Dowdy S, Feitoza SS, Gostout BS, Podratz KC. Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol Oncol. 2004;94(3):655\u201360. https:\/\/doi.org\/10.1016\/j.ygyno.2004.04.032.","journal-title":"Gynecol Oncol."},{"key":"18423_CR22","unstructured":"R core team. R Core Team (2020). \u2014 European Environment Agency. Accessed August 31, 2022. https:\/\/www.eea.europa.eu\/data-and-maps\/indicators\/oxygen-consuming-substances-in-rivers\/r-development-core-team-2006"},{"issue":"5","key":"18423_CR23","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.ajog.2004.02.034","volume":"190","author":"H Trinh","year":"2004","unstructured":"Trinh H, Ott C, Fanning J. Feasibility of laparoscopic debulking with electrosurgical loop excision procedure and argon beam coagulator at recurrence in patients with previous laparotomy debulking. Am J Obstet Gynecol. 2004;190(5):1394\u20137. https:\/\/doi.org\/10.1016\/j.ajog.2004.02.034.","journal-title":"Am J Obstet Gynecol."},{"issue":"12","key":"18423_CR24","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.ejso.2022.06.007","volume":"48","author":"K Kuusela","year":"2022","unstructured":"Kuusela K, Norppa N, Auranen A, Saarelainen S. Maximal surgical effort increases the risk of postoperative complications in the treatment of advanced ovarian cancer. Eur J Surg Oncol. 2022;48(12):2525\u201330. https:\/\/doi.org\/10.1016\/j.ejso.2022.06.007.","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"18423_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/jcm14020470","volume":"14","author":"P Salas Bol\u00edvar","year":"2025","unstructured":"Salas Bol\u00edvar P, Gonzalez-Benitez C, Carbonell L\u00f3pez M, D\u00edez Sebastian J, Hern\u00e1ndez Guti\u00e9rrez A, Zapardiel I. Prognostic Factors After the First Recurrence of Ovarian Cancer. J Clin Med. 2025;14(2):470. https:\/\/doi.org\/10.3390\/jcm14020470.","journal-title":"J Clin Med."}],"updated-by":[{"DOI":"10.1245\/s10434-025-18589-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000}}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18423-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18423-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18423-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:32:41Z","timestamp":1767573161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18423-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["18423"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18423-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,4]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1245\/s10434-025-18589-8","URL":"https:\/\/doi.org\/10.1245\/s10434-025-18589-8","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}